BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3288057)

  • 1. Brain ischemia as a target for Ca2+ entry blockers.
    Wauquier A; Ashton D; Clincke GH
    Ann N Y Acad Sci; 1988; 522():478-90. PubMed ID: 3288057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium antagonists and cerebrovascular circulation].
    De Gregorio C
    Clin Ter; 1987 Oct; 123(1):41-50. PubMed ID: 2972466
    [No Abstract]   [Full Text] [Related]  

  • 3. [The influence of cinnarizine and alvityl on cerebral blood flow and high nervous activity in chronic cerebral ischemia model].
    Gromova OA; Grishina TR; Sadin AV; Nikonov AA; Nazarenko OA; Zhidomorov NIu; Vatsuro AA; Borzunov MP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):52-3. PubMed ID: 14870694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cerebral circulation and calcium antagonists].
    Uematsu D; Fukuuchi Y
    No To Shinkei; 1990 Jan; 42(1):17-31. PubMed ID: 2186763
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cerebral protective effects by continuous administration of a calcium antagonist after canine global brain ischemia--change in cerebral blood flow and metabolism].
    Ono K; Iwatsuki N; Obara S; Hashimoto Y
    Masui; 1988 Jan; 37(1):23-8. PubMed ID: 3367498
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical benefit of slow calcium channel antagonists in cerebral ischaemia.
    Lapalus P; Drici MD; Iacono P
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():134A. PubMed ID: 1498781
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cerebrovascular circulation and metabolism. Action of calcium overload blockers].
    Fortschr Med Suppl; 1985; 8():10-1. PubMed ID: 2867017
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium channel blockers and cerebral circulation].
    Uematsu D; Fukuuchi Y
    Nihon Rinsho; 1989 Aug; 47(8):1770-5. PubMed ID: 2585739
    [No Abstract]   [Full Text] [Related]  

  • 11. Flow thresholds in brain ischaemia and the effects of drugs.
    Symon L
    Br J Anaesth; 1985 Jan; 57(1):34-43. PubMed ID: 3881114
    [No Abstract]   [Full Text] [Related]  

  • 12. [Brain protection must be simultaneously specific and complex. Versatile effect of certain calcium antagonists].
    Fortschr Med Suppl; 1985; 8():18-9. PubMed ID: 2867022
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible role of calcium blockers in cerebral resuscitation: a review of the literature and synthesis for future studies.
    White BC; Winegar CD; Wilson RF; Hoehner PJ; Trombley JH
    Crit Care Med; 1983 Mar; 11(3):202-7. PubMed ID: 6339166
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy in the early stage of cerebral insufficiency. Clinical and technical possibilities for evaluating the vascular system].
    Fortschr Med Suppl; 1986; 1():9-10. PubMed ID: 2868982
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the intracellular calcium antagonist HA1004 on cerebral blood flow in rats.
    Okada T; Shibuya M; Suzuki Y; Ikegaki I; Kageyama N; Asano T; Hidaka H
    Neurol Med Chir (Tokyo); 1988 Jul; 28(7):625-30. PubMed ID: 2462166
    [No Abstract]   [Full Text] [Related]  

  • 16. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.
    Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M
    J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.
    Gomi S; Burnett MG; Karp A; Greenberg JH
    Exp Brain Res; 2004 Apr; 155(4):469-76. PubMed ID: 14752581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of betaserk and cinarizine on vestibular function, highest nervous activity and brain circulation in chronic cerebral ischemia: a model study].
    Grishina TR; Gromova OA; Sadin AV; Nazarenko OA; Zhidomorov NIu; Borzunov MP; Vatsuro AA; Nikonov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(2):61-3. PubMed ID: 15002324
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium antagonist (PY 108-068) treatment may further decrease flow in ischemic areas in acute stroke.
    Vorstrup S; Andersen A; Blegvad N; Paulson OB
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):222-9. PubMed ID: 3485642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathologic bases and prospects in the prevention and medical therapy of vascular brain diseases with an ischemic base].
    Peruzzi G; Raimondi G; Baldoni F; Grimaldi I; Di Nardo P; Bellegrandi F; Tallarida G
    Clin Ter; 1987 Feb; 120(4):275-98. PubMed ID: 2953529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.